News: $IBRX (-0,75 %) US FDA approves bladder cancer therapy from ImmunityBio!
Very positive for the rest of the pipeline ... lets go!
News: $IBRX (-0,75 %) US FDA approves bladder cancer therapy from ImmunityBio!
Very positive for the rest of the pipeline ... lets go!